EFFECT OF CONTINUOUS ADMINISTRATION OF INTERFERON-GAMMA IN EXPERIMENTAL VISCERAL LEISHMANIASIS

被引:73
作者
MURRAY, HW
机构
[1] Division of Infectious Diseases, Cornell University Medical College, New York, NY
关键词
D O I
10.1093/infdis/161.5.992
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In experimental visceral leishmaniasis, intermittently administered Interferon-γ (IFN-γ) induces antileishmanial activity, which is primarily microbistatic. To determine if the efficacy of IFN-γ immunotherapy could be enhanced by continuous delivery, Leishmania donovani-infected mice were treated using a subcutaneous osmotic pump. Once-daily intraperitoneal injections of 105 or 106 units of IFN-γ; inhibited the replication of L. donovani within liver macrophages but overall did not reduce liver parasite burdens. In contrast, a comparable dose of IFN-γ (2.4 x 105 units/day) administered continuously induced an enhanced effect and reduced liver burdens by almost 50%. Although pump delivery did not similarly increase the efficacy of antimony chemotherapy in infected mice, continuous treatment with IFN-γ plus antimony produced an additive antileishmanial effect.These results suggest that continuous infusions ofmacrophage-activating lymphokines such as IFN-γ (used alone or in combination with chemotherapy) may be required to optimize in vivo antimicrobial effects. © 1990 by the University of Chicago. All rights reserved.
引用
收藏
页码:992 / 994
页数:3
相关论文
共 20 条
[11]   REQUIREMENT FOR T-CELLS AND EFFECT OF LYMPHOKINES IN SUCCESSFUL CHEMOTHERAPY FOR AN INTRACELLULAR INFECTION - EXPERIMENTAL VISCERAL LEISHMANIASIS [J].
MURRAY, HW ;
OCA, MJ ;
GRANGER, AM ;
SCHREIBER, RD .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 83 (04) :1253-1257
[13]   KILLING OF INTRACELLULAR LEISHMANIA-DONOVANI BY LYMPHOKINE-STIMULATED HUMAN MONONUCLEAR PHAGOCYTES - EVIDENCE THAT INTERFERON-GAMMA IS THE ACTIVATING LYMPHOKINE [J].
MURRAY, HW ;
RUBIN, BY ;
ROTHERMEL, CD .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (04) :1506-1510
[14]  
MURRAY HW, 1987, J IMMUNOL, V138, P2290
[15]   IMMUNOCHEMOTHERAPY FOR INTRACELLULAR LEISHMANIA-DONOVANI INFECTION - GAMMA-INTERFERON PLUS PENTAVALENT ANTIMONY [J].
MURRAY, HW ;
BERMAN, JD ;
WRIGHT, SD .
JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (05) :973-978
[16]  
MURRAY HW, 1987, J IMMUNOL, V138, P2457
[17]  
SACKS DL, 1987, J IMMUNOL, V138, P908
[18]  
STERN JJ, 1988, J IMMUNOL, V140, P3971
[19]   PHASE-I TRIAL OF RECOMBINANT INTERFERON-GAMMA IN CANCER-PATIENTS [J].
VADHANRAJ, S ;
ALKATIB, A ;
BHALLA, R ;
PELUS, L ;
NATHAN, CF ;
SHERWIN, SA ;
OETTGEN, HF ;
KROWN, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (02) :137-146
[20]  
Wijers D J, 1971, East Afr Med J, V48, P551